Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 11/20 | 0.50 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.47 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.44 |
| ▸ | ALB | P02768 | 1/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.44 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.44 |
| ▸ | GHSR | Q92847 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4903311 | 0.88 | AR (0.52) | ARTAS2R14SLC22A12PGR | |
| SCHEMBL3289362 | 0.85 | AR (0.55) | ARTAS2R14SLC22A12PGR | |
| SCHEMBL1291418 | 0.83 | TAS2R14 (0.51) | ARTAS2R14SLC22A12CYP2C19ABCB11 | |
| SCHEMBL1363115 | 0.83 | TAS2R14 (0.51) | ARTAS2R14SLC22A12CYP2C19ABCB11 | |
| SCHEMBL1363920 | 0.83 | TAS2R14 (0.51) | ARTAS2R14SLC22A12CYP2C19ABCB11 | |
| SCHEMBL12140104 | 0.83 | TAS2R14 (0.51) | ARTAS2R14SLC22A12CYP2C19ABCB11 | |
| SCHEMBL3290604 | 0.82 | AR (0.52) | ARTAS2R14SLC22A12PGR | |
| SCHEMBL13747842 | 0.82 | AR (0.48) | ARTAS2R14SLC22A12CYP2C19ABCB11 | |
| SCHEMBL15712966 | 0.82 | TAS2R14 (0.47) | ARTAS2R14SLC22A12CYP2C19ABCB11 | |
| SCHEMBL5120802 | 0.82 | AR (0.49) | ARTAS2R14SLC22A12CYP2C19ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9920044-B2 | Selective androgen receptor modulators | RADIUS PHARMACEUTICALS, INC. (US) | 2018-03-20 | — | — | US | disclosed |